Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph phase_4
2
29%
Ph phase_2
1
14%
Ph phase_3
2
29%
Ph not_applicable
2
29%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 32 (28.6%)
Phase 42 (28.6%)
N/A2 (28.6%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

NCT00644033
completedphase_2

Frovatriptan as a Transitional Therapy in Medication Overuse Headache

NCT01044251
completedphase_3

A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine

NCT00821483
completedphase_4

Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine

NCT00846495
completednot_applicable

Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals

NCT00700128
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00644033Phase 3

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

Completed
NCT01044251Phase 2

Frovatriptan as a Transitional Therapy in Medication Overuse Headache

Completed
NCT00821483Phase 3

A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine

Completed
NCT00846495Phase 4

Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine

Completed
NCT00700128Not Applicable

Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals

Completed
NCT00440232Not Applicable

A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting

Completed
NCT00904098Phase 4

Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7